For example, nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related MASLD through the regulation of peroxisome proliferator-activated receptor γ (15). This evidence concerns the gene PTGS2 and obesity due to melanocortin 4 receptor deficiency.